Parthenolide prevents resistance of MDA-MB231 cells to doxorubicin and mitoxantrone: the role of Nrf2

Triple-negative breast cancer is a group of aggressive cancers with poor prognosis owing to chemoresistance, recurrence and metastasis. New strategies are required that could reduce chemoresistance and increases the effectiveness of chemotherapy. The results presented in this paper, showing that par...

Descripción completa

Detalles Bibliográficos
Autores principales: Carlisi, Daniela, De Blasio, Anna, Drago-Ferrante, Rosa, Di Fiore, Riccardo, Buttitta, Giuseppina, Morreale, Marco, Scerri, Christian, Vento, Renza, Tesoriere, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5712634/
https://www.ncbi.nlm.nih.gov/pubmed/29354292
http://dx.doi.org/10.1038/cddiscovery.2017.78

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5712634/
https://www.ncbi.nlm.nih.gov/pubmed/29354292
http://dx.doi.org/10.1038/cddiscovery.2017.78

Ejemplares similares